Tudor Investment Corp ET AL acquired a new position in Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 14,343 shares of the oil and gas company’s stock, valued at approximately $1,453,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Clearbridge Investments LLC boosted its stake in Core Laboratories N.V. by 3.8% during the first quarter. Clearbridge Investments LLC now owns 5,219,879 shares of the oil and gas company’s stock valued at $603,000,000 after buying an additional 190,186 shares in the last quarter. WCM Investment Management CA raised its holdings in shares of Core Laboratories N.V. by 7.3% in the 2nd quarter. WCM Investment Management CA now owns 4,433,175 shares of the oil and gas company’s stock worth $448,948,000 after purchasing an additional 303,073 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Core Laboratories N.V. by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 3,672,865 shares of the oil and gas company’s stock worth $371,950,000 after purchasing an additional 56,807 shares in the last quarter. Sustainable Growth Advisers LP raised its holdings in shares of Core Laboratories N.V. by 36.9% in the 2nd quarter. Sustainable Growth Advisers LP now owns 2,345,271 shares of the oil and gas company’s stock worth $237,505,000 after purchasing an additional 632,263 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its holdings in shares of Core Laboratories N.V. by 1.3% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,702,000 shares of the oil and gas company’s stock worth $172,364,000 after purchasing an additional 22,276 shares in the last quarter.

A number of equities research analysts have recently commented on CLB shares. Zacks Investment Research upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research report on Monday, June 12th. Royal Bank Of Canada set a $145.00 target price on Core Laboratories N.V. and gave the stock a “buy” rating in a research report on Saturday, June 17th. BidaskClub raised Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 13th. Piper Jaffray Companies set a $97.00 target price on Core Laboratories N.V. and gave the company a “hold” rating in a report on Wednesday, July 26th. Finally, ValuEngine raised Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $113.58.

Core Laboratories N.V. (NYSE CLB) traded down 0.24% during trading on Tuesday, hitting $98.45. 24,770 shares of the stock were exchanged. The firm has a market capitalization of $4.35 billion, a PE ratio of 60.40 and a beta of 1.63. The stock has a 50 day moving average price of $92.88 and a 200-day moving average price of $103.06. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last released its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, topping the Zacks’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The company had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. During the same quarter last year, the firm posted $0.35 earnings per share. Core Laboratories N.V.’s revenue was up 10.7% compared to the same quarter last year. On average, equities research analysts anticipate that Core Laboratories N.V. will post $1.99 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Tudor Investment Corp ET AL Purchases New Stake in Core Laboratories N.V. (CLB)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/tudor-investment-corp-et-al-purchases-new-stake-in-core-laboratories-n-v-clb/1605412.html.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.